TrialActa obstetricia et gynecologica Scandinavica2024

Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial.

Marta Ricart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.